The S&P 500 has broken trendline resistance and is above all its daily moving averages. Read more about the bullish technical outlook.Read full newsRead More
We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. Read more here.Read full newsRead More
Real estate equities continued their hot start to 2023 as earnings season kicked off. The Equity REIT Index advanced another 3.0% while Mortgage REITs gained 2.5%.Read full newsRead More
Underlying cash profitability for Amazon is inconsistent and sometimes negative. Click here to see our take on AMZN stock.Read full newsRead More
Less than 2 years ago, New Oriental was fighting fur survival and share price collapsed to multi-year lows. Read more to see my recommendation on EDU stock.Read full newsRead More
OPEC crude output was revised lower in October 2022 by 12 kb/d compared to last month's report and November 2022 OPEC crude output was revised higher by 53 kb/d.Read full newsRead More
Intel has seen a tough Q4 in 2022 and the Q1 guidance for 2023 is particularly underwhelming. Read more to see a full investment analysis of INTC stock.Read full newsRead More
Shares of Blackstone have seen a very strong performance in 2023. Click here to read my analysis of BX stock.Read full newsRead More
Yesterday's weekly update on initial jobless claims suggests that the labor market will continue expanding.Read full newsRead More
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.Read full newsRead More
KDDI experiences stabilizing user churn and rising ARPU via 5G adoption. Click here to read more on why we are bullish on the name.Read full newsRead More
While COVID certainly contributed to Crocs' impressive business expansion starting early 2020, it is unlikely to be the sole driver. CROX is a Buy; here's why.Read full newsRead More
Given price action and market breadth, I'm still leaning positive for the S&P 500 to definitely break the downtrend line in place since January '22.Read full newsRead More
Aerovate is a SMID-cap biotech developing an inhaled imatinib for pulmonary arterial hypertension. See why we initiate with a buy rating on AVTE stock.Read full newsRead More
Valaris looks geared to benefit from the upswing in offshore exploration, provided it can calibrate its fleet correctly. Click here to see our take on VAL.Read full newsRead More
AT&T reported better than expected Q4'22 earnings. Free cash flow was $14.1B and the FCF outlook for the current year is very strong. Read more here.Read full newsRead More
Five9 posted continued growth in its top line, thanks to its growing enterprise customer base and innovative product portfolio. See why I'm neutral on FIVN stock.Read full newsRead More
Following its acquisition, we believe QuidelOrtho's Labs segment has solid growth opportunities. Click here to see our take on QDEL stock.Read full newsRead More
Now may be a great time to add or increase your REIT exposure to your portfolio. Read more to see our approach.Read full newsRead More
The idea of a soft landing is only a reality if you exclude, in most cases, rather devasting financial consequences. Learn more about soft landing scenario.Read full newsRead More